期刊文献+

骨桥蛋白剪接变体对胶质瘤细胞侵袭性的影响 被引量:1

The effects of osteopontin splicing variants on glioma cell invasion in vitro
下载PDF
导出
摘要 目的探讨骨桥蛋白(OPN)剪接变体对胶质瘤细胞侵袭性的影响及其作用机制。方法采用荧光定量聚合酶链反应或逆转录-聚合酶链反应分别检测正常脑组织、WHOⅡ~Ⅳ级胶质瘤组织,以及人胶质瘤细胞系U251、U87、SHG44和TJ905骨桥蛋白各剪接变体表达水平;小干扰RNA(siRNA)技术沉默野生型骨桥蛋白,慢病毒质粒表达载体分别导入三种突变型剪接变体OPN-a、OPN-b和OPN-c;细胞体外侵袭实验检测U251和U87细胞体外侵袭力。整合素α_vβ_3受体抗体和磷脂酰肌醇3-激酶(PI_3K)抑制剂LY294002抑制骨桥蛋白的作用,阻断PI_3K/Akt信号转导通路。Western blotting法检测侵袭相关蛋白尿激酶型纤溶酶原激活物(uPA)、基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)表达水平,以及丝氨酸/苏氨酸蛋白激酶AKT磷酸化水平和核因子-κB(NF-κB)p65转录进入细胞核水平,明胶酶谱法检测MMP-2和MMP-9活性。结果 WHOⅢ~Ⅳ级胶质瘤组织,以及U251和U87细胞骨桥蛋白各剪接变体呈高表达,而正常脑组织、WHOⅡ级胶质瘤组织及SHG44和TJ905细胞呈低表达。OPN-a和OPN-c可升高U251和U87细胞AKT磷酸化水平,诱导NF-κB p65转录进入细胞核,提高uPA、MMP-2和MMP-9表达水平,增强MMP-2和MMP-9活性,从而增强胶质瘤细胞侵袭力;OPN-b对胶质瘤细胞侵袭力无明显作用。结论 OPN-a和OPN-c通过激活PI_3K/Akt/NF-κB信号转导通路而增强胶质瘤细胞侵袭力。 Objective To investigate the role and mechanism of osteopontin (OPN) splicing variants (OPN-a, OPN-b, OPN-c)on glioma cell invasion in vitro: Methods The relative expression of OPN splicing variants in normal brain tissue, World Health Organization (WHO) Ⅱ -Ⅳ glioma tissues, and human glioma cell lines U251, U87, SHG44 and TJ905 were determined by real- time fluorescence quantitative polymerase chain reaction (PCR) and reverse transcriptase (RT)-PCR. Wild OPN was knocked down by small interference RNA (siRNA) and transfected with OPN splicing variants, respectively. Additionally, anti-integrin α,β antibody and phosphoinostide 3-kinase (PLK) inhibitor LY294002 were used to block the binding of OPN and PI3K/Akt signal transduction pathway, respectively. Invasion related- proteins, urokinase, type plasminogen activator (uPA), matrix metalloproteinase- 2 (MMP- 2), matrix metalloproteinase-9 (MMP-9), pAKT and nuclear factor-κB (NF-κB) were determined by Transwell assay, Western blotting and gelatin zymography. Results OPN-a, OPN-b and OPN-c high expression were seen in WHO Ⅲ-Ⅳ glioma tissues and U251 and U87 cells, while low expression in normal brain tissue, WHO Ⅱ glioma tissue and SHG44 and TJ905 cells. Over-expression OPN-a and OPN-c up-regulated uPA, MMP- 2, MMP-9, pAKT and NF-κB expression and promoted U251 and U87 cells invasion. Over-expression OPN- b had no obvious effect on invasion. Conclusion OPN-a and OPN-c, but not OPN-b promote U251 and U87 cells invasion by activation of PI3K/Akt/NF-κB signal transduction pathway.
出处 《中国现代神经疾病杂志》 CAS 2009年第6期562-570,共9页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 国家自然科学基金资助项目(项目编号:30672165) 江苏省医学重点人才项目(项目编号:RC2007061)
关键词 骨桥蛋白质 剪接体 脑肿瘤 神经胶质瘤 聚合酶链反应 衔接蛋白质类 信号转导 Osteopontin Splieeosomes Brain neoplasms Glioma Polymerase chain reaction Adaptor proteins, signal transducing
  • 相关文献

参考文献21

  • 1Sodek J, Ganss B, McKee MD. Osteopontin. Crit Rev Oral Biol Med, 2000, 11:279-303.
  • 2Young MF, Kerr JM, Termine JD, et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics, 1990, 7:491- 502.
  • 3Saitoh Y, Kuratsu J, Takeshima H, et al. Expression of osteopontin in human glioma: its correlation with the malignancy. Lab Invest, 1995, 72:55-63.
  • 4Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res, 2004, 121:228-241.
  • 5Likui W, Hong W, Shuwen Z. Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer. J Gastrointest Surg, 2009. [Epub ahead of print].
  • 6Shevde LA, Das S, Clark DW, et al. Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med, 2009. [Epub ahead of print].
  • 7Song JY, Lee JK, Lee NW, et al. Osteopontin expression correlates with invasiveness in cervical cancer. Aust N Z J Obstet Gynaecol, 2009, 49:434-438.
  • 8He B, Mirza M, Weber GF. An osteopontin splice variant induces anchorage independence in human breast cancer cells. Oncogene, 2006, 25:2192-2202.
  • 9Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007, 114:97-109.
  • 10Chakraborty G, Jain S, Patil TV, et al. Down- regulation of osteopontin attenuates breast tumor progression in vivo. J Cell Mol Med, 2008, 12:2305-2318.

二级参考文献13

  • 1Rudland PS, Platt-Higgins A, El-Tanani M, et al. Prognostic significance of the metastasis associated protein osteopontin in human breast cancer [J]. Cancer Res, 2002, 62(12): 3417-3427.
  • 2Pan HW, Ou YH, Peng SY, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma [J]. Cancer, 2003, 98(1): 119-127.
  • 3Le QT, Sutphin PD, Raychaudhuri S, et al . Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas [J]. Clin Cancer Res, 2003,9(1): 59-67.
  • 4Anthomy O, effrey S. Osteopontin: key cytokine in cellmediated and granulomatous inflammation [J]. Int J Exp Patho, 2000, 8(12): 373-390.
  • 5Furger KA, Menon RK, Tuckl AB, et al. The functional and clinical roles of osteopontin in cancer and metastasis[J]. Curr Mol Med, 2001, 1(5): 621-632.
  • 6Yeatman TJ, Chambers AF. Osteopontin and colon cancer progression [J]. Clin Exp Metastasis, 2003, 20(1): 852-980.
  • 7Prols F, Loser B, Marxm M. Differential expression of osteopontin, PC4,and CEC5, a novel mBNA species, during in vitro angiogenesis [J].Exp Cell Res, 1998, 239(1): 1-10.
  • 8Hirama M, Takahashif F, TaakahashikI K, et al. Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth [J]. Cancer Lett, 2003,198(1): 107-117.
  • 9Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy [J]. Biochim Biophys Acta, 2001,52(2): 61-85.
  • 10Hirohito Yano,Akira Hara,Satoru Murase,Katsuhiko Hayashi,Hiromichi Ando,Jun Shinoda,Kuniyasu Shimokawa,Noboru Sakai. Expression of hepatocyte growth factor and matrix metalloproteinase-2 in human glioma[J] 2001,Brain Tumor Pathology(1):7~12

共引文献7

同被引文献19

  • 1曾涛,杨卫忠,石松生,张国良,王春华.骨桥蛋白在中枢神经系统中多种恶性肿瘤的表达[J].中国临床神经科学,2007,15(5):455-458. 被引量:2
  • 2O' Regan a,berman JS.Osteopont in:a key cytokine in cell-mediated and granulomatous inflamation[J].Int J Exp Pathol,2000,8:373-390.
  • 3Mi Z,Guo H,Russel MB,et al. RNA aptamer blockade of osteopontin in hinbits growth and metastasis of MDA-MB231 breast cancer cells [J].Mol Ther,2009,17 (1):153-161.
  • 4Jain S,Chakraborty G. Osteopontin: an emerging therapeu- tic targetforanticancer therapy [J]. Expert Opin Ther Tar-gets,2007,11 ( 1 ):81-90.
  • 5Riberiro-Silva A,Oliveira da Costa JE Osteopontin expers- sion according to molecular profile of invasive breast can- cer: a clinicopathologieal and immunohistochemical syudy [J]. Int J Biol Markers,2008,23(3) : 154-160.
  • 6Chakraborty G, Jain S,Kundu GC.Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms [ J ].Cancer Res, 2008,68 ( 1 ): 152-161.
  • 7Weismann D,Briese J,Niemann J, et aL Osteopotin stimu- lates invasion of NCI-H295 cells but is not associated with survival in adrenocortical carcinoma[J]. J Pathol, 2009, 218(2):232-240.
  • 8Chen YJ ,Wei YY, Chen HT et al.Osteopotin increases mi- gration and MMP-9 up-regualstion viactv133 integrin,FAK, ERK,and NF-r,B-dependent pathway in hunman chondro- sarcoma cells [J].J Cell, Physiol, 2009,221 ( 1 ):98-108.
  • 9Cho H, Hong SW, Oh YJ, et al. Clinical significance of os- teopontin expression in cervical cancer [J]. J Cancer Res Clin Oncol,2008,134(8):909-917.
  • 10Behera R, Kumar V, Lohite K, et al. Activation of JAK2/ STAT3 signaling by osteopotin promotes tumor growth in human breast cancer cells [J]. Carcinogenesis, 2010, 31: 192-200.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部